113 related articles for article (PubMed ID: 26411010)
1. In vitro Toxicity and in vivo Immunomodulatory Effects of Flavokawain A and Flavokawain B in Balb/C Mice.
Abu N; Mohameda NE; Tangarajoo N; Yeap SK; Akhtar MN; Abdullah MP; Omar AR; Alitheen NB
Nat Prod Commun; 2015 Jul; 10(7):1199-202. PubMed ID: 26411010
[TBL] [Abstract][Full Text] [Related]
2. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Zi X; Simoneau AR
Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice.
Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
Anticancer Agents Med Chem; 2015; 15(7):905-15. PubMed ID: 26179368
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of Flavokawains A, B, and C, Chalcones from Kava (Piper methysticum), by Human Liver Microsomes.
Zenger K; Agnolet S; Schneider B; Kraus B
J Agric Food Chem; 2015 Jul; 63(28):6376-85. PubMed ID: 26123050
[TBL] [Abstract][Full Text] [Related]
5. Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NF
Yang HL; Yang TY; Gowrisankar YV; Liao CH; Liao JW; Huang PJ; Hseu YC
Oxid Med Cell Longev; 2020; 2020():3476212. PubMed ID: 32617135
[TBL] [Abstract][Full Text] [Related]
6. Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
Jeong HJ; Lee CS; Choi J; Hong YD; Shin SS; Park JS; Lee JH; Lee S; Yoon KD; Ko J
Bioorg Med Chem Lett; 2015 Feb; 25(4):799-802. PubMed ID: 25597012
[TBL] [Abstract][Full Text] [Related]
7. Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.
Pinner KD; Wales CT; Gristock RA; Vo HT; So N; Jacobs AT
Pharm Biol; 2016 Sep; 54(9):1503-12. PubMed ID: 26789234
[TBL] [Abstract][Full Text] [Related]
8. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages.
Kwon DJ; Ju SM; Youn GS; Choi SY; Park J
Food Chem Toxicol; 2013 Aug; 58():479-86. PubMed ID: 23727179
[TBL] [Abstract][Full Text] [Related]
9. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Abdullah MP; Ho CL; Omar AR; Ismail J; Alitheen NB
BMC Complement Altern Med; 2016 Feb; 16():86. PubMed ID: 26922065
[TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398
[TBL] [Abstract][Full Text] [Related]
11. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.
Tang Y; Simoneau AR; Xie J; Shahandeh B; Zi X
Cancer Prev Res (Phila); 2008 Nov; 1(6):439-51. PubMed ID: 19138991
[TBL] [Abstract][Full Text] [Related]
12. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.
Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L
Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367
[TBL] [Abstract][Full Text] [Related]
13. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.
Zhou P; Gross S; Liu JH; Yu BY; Feng LL; Nolta J; Sharma V; Piwnica-Worms D; Qiu SX
FASEB J; 2010 Dec; 24(12):4722-32. PubMed ID: 20696856
[TBL] [Abstract][Full Text] [Related]
14. The flavokawains: uprising medicinal chalcones.
Abu N; Ho WY; Yeap SK; Akhtar MN; Abdullah MP; Omar AR; Alitheen NB
Cancer Cell Int; 2013 Oct; 13(1):102. PubMed ID: 24148263
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of both kavalactone and flavokawain constituents by different single-marker methods in kava.
Zhao X; Su C; Ren R; Zhang B; Wang Y; Su X; Lu F; Zong R; Yang L; Zhang W; Ma X
J Sep Sci; 2021 Jul; 44(14):2705-2716. PubMed ID: 33951745
[TBL] [Abstract][Full Text] [Related]
16. Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model.
Wei Z; Gu X; Zhang J; Chen Y; Jiang T; Hu D; Miao M; Zhou H; Cheng R; Teichmann AT; Yang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116896. PubMed ID: 37437790
[TBL] [Abstract][Full Text] [Related]
17. Flavokawain C exhibits anti-tumor effects on in vivo HCT 116 xenograft and identification of its apoptosis-linked serum biomarkers via proteomic analysis.
Phang CW; Abd Malek SN; Karsani SA
Biomed Pharmacother; 2021 May; 137():110846. PubMed ID: 33761587
[TBL] [Abstract][Full Text] [Related]
18. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro.
Celentano A; Yiannis C; Paolini R; Zhang P; Farah CS; Cirillo N; Yap T; McCullough M
Sci Rep; 2020 Sep; 10(1):15904. PubMed ID: 32985597
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
Thieury C; Lebouvier N; Le Guével R; Barguil Y; Herbette G; Antheaume C; Hnawia E; Asakawa Y; Nour M; Guillaudeux T
Bioorg Med Chem; 2017 Mar; 25(6):1817-1829. PubMed ID: 28214231
[TBL] [Abstract][Full Text] [Related]
20. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
Liu Z; Xu X; Li X; Liu S; Simoneau AR; He F; Wu XR; Zi X
Cancer Prev Res (Phila); 2013 Dec; 6(12):1365-75. PubMed ID: 24121102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
